CNA CNA FINANCIAL CORP Insider Trading

CNA CFO Scott Lindquist sold 18,380 shares across 2 transactions for $898,552.40 on Sept 3-4, retaining 81,487 shares post-sale.

CNA Financial CFO Scott R. Lindquist executed two separate sales on September 3-4, 2025, totaling 18,380 shares at a blended average price of $48.89, generating $898,552.40. The sale reduced his holdings by 18.4% from the pre-transaction level of 99,867 shares to 81,487 shares post-transaction. The blended transaction prices ($48.81 and $48.98) were slightly above the current market price of $48.01, placing the trade near recent price levels within the stock's 52-week range of $43.33–$51.95. With the company's fundamentals showing revenue of $3.7B, net income of $299.0M, and a P/E of 14.82, the transaction itself—a moderate reduction in the CFO's stake—does not obviously indicate a material concern about company prospects, though any substantial insider sale warrants routine investor attention.

CNA Financial Chairman Robusto Dino buys 3,896 shares for $185,573.28 at $47.63

Robusto Dino completed two separate purchases totaling 3,896 shares for $185,573.28 at a blended average price of $47.63 on 2025-03-13. This represents a 0.5% increase to his holdings of 724,338 shares post-transaction. The shares were purchased at a price approximately 3.3% below the current market price of $49.26 and roughly 8.8% below the 52-week high of $51.95. CNA Financial trades at a P/E of 12.60 with net income of $283,000,000.00 and annual revenue growth of 7.3%, indicating a modestly valued business with consistent fundamentals. The transaction occurred within normal trading parameters and reflects a modest increment to an already substantial personal shareholding by the Executive Chairman.

CNA EVP Douglas Worman sells 22,973 shares at $48.75; retains 133,777 shares post-sale

Douglas Worman, EVP & Head of Underwriting at CNA Financial, sold 22,973 shares at $48.75 on 2024-11-07, reducing his holding by 14.7% from 156,750 to 133,777 shares. His prior sale at this ticker on 2023-11-17 was poorly timed: the stock rose 17.7% in the 90 days following that sale, indicating the insider sold before a significant rally. The current transaction occurs at $48.75, which is 7.0% below the 52-week high of $51.95 and near recent trading levels (30-day change: -1.4%). CNA trades at a 10.03 P/E with $3.6B in quarterly revenue and 12.0% annual revenue growth, suggesting stable fundamentals. Without scheduled trade documentation (10b5-1), the pattern of sales continues; however, the company's operational strength and prior misvaluation of the 2023 sell call for contextual attention to whether this transaction reflects new information or continued discretionary portfolio adjustment.

EVP/Chief HR Officer Elizabeth Ann Aguinaga sold 26,160 shares of CNA at $49.60, reducing stake 35.4% to 47.7K shares; stock near 52-week highs.

Elizabeth Ann Aguinaga, serving as EVP and Chief HR Officer, executed a sale of 26,160 shares at $49.60 on 2024-08-20, valued at $1,297,536.00. This sale reduced her holdings from 73,904 shares to 47,744 shares, representing a -35.4% reduction in her pre-transaction position. The transaction occurred when CNA's stock was trading at $49.60, approximately 0.6% below its 52-week high of $49.89, in an environment where the stock has appreciated 4.8% over 30 days and 12.6% over 90 days. CNA's fundamentals show solid performance with $3.5B in quarterly revenue, $317.0M in net income, and 12.0% annual revenue growth, while trading at a P/E of 10.49 with a $13.4B market capitalization. The sale represents a discretionary reduction of a substantial portion of her holdings during a period of relative strength in the stock.